Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN
Malak Ghaddar, Fernando Caravaca‐Fontán, Manuel Praga, Gema Fernández‐Juárez, Hannah J. Lomax-Browne, H. Terence Cook, Erica Daina, Marina Noris, Giuseppe Remuzzi, Dilshani Induruwage, Bingyue Zhu, Matthew C. Pickering, Sean J. Barbour (2025). Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN. , 20(8), DOI: https://doi.org/10.2215/cjn.0000000751.
Article65 days agoAn expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group
Carla Nester, David L. Feldman, Richard M. Burwick, Spero R. Cataland, Shruti Chaturvedi, H. Terence Cook, Adam Cuker, Bradley P. Dixon, Fádi Fakhouri, Sangeeta Hingorani, Anuja Java, Nicole C. A. J. van de Kar, David Kavanagh, Nelson Leung, Christoph Licht, Marina Noris, Michelle M. O’Shaughnessy, Samir V. Parikh, Flora Peyandi, Giuseppe Remuzzi, Richard J. Smith, C. John Sperati, Meryl Waldman, Patrick D. Walker, Marina Vivarelli (2024). An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group. , 106(3), DOI: https://doi.org/10.1016/j.kint.2024.05.021.
Article65 days agoThe role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Marina Vivarelli, Jonathan Barratt, Laurence H. Beck, Fádi Fakhouri, Daniel P. Gale, Elena Goicoechea de Jorge, Marta Mosca, Marina Noris, Matthew C. Pickering, Katalin Suszták, Joshua M. Thurman, Michael Cheung, Jennifer King, Michel Jadoul, Wolfgang C. Winkelmayer, Richard J. Smith, Federico Alberici, Luca Antonucci, Tadej Avčin, Arvind Bagga, Ingeborg M. Bajema, Miquel Blasco, Sophie Chauvet, H. Terence Cook, Paolo Cravedi, Marie‐Agnès Dragon‐Durey, Lauren Fischer, Agnes B. Fogo, Ashley Frazer‐Abel, Véronique Frémeaux‐Bacchi, Nina Görlich, Mark Haas, Alister Humphreys, Vivekanand Jha, Arenn Jauhal, David Kavanagh, Andreas Kronbichler, Richard Lafayette, Lynne D. Lanning, Mathieu Lemaire, Moglie Le Quintrec, Christoph Licht, Adrian Liew, Stephen P. McAdoo, Nicholas Medjeral‐Thomas, Pier Luigi Meroni, Johann Morelle, Carla Nester, Manuel Praga, Raja Ramachandran, Heather N. Reich, Giuseppe Remuzzi, Santiago Rodrı́guez de Córdoba, Gary Robinson, Pierre Ronco, Peter Rossing, David J. Salant, Sanjeev Sethi, Marianne Silkjaer, Wen‐Chao Song, Fabrizio Spoleti, Ronald P. Taylor, Nicole C. A. J. van de Kar, Cees van Kooten, Len Woodward, Yuzhou Zhang, Peter F. Zipfel, Marco Zuccato (2024). The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 106(3), DOI: https://doi.org/10.1016/j.kint.2024.05.015.
Article65 days agoClinical and Histological Predictors of Outcomes in C3 Glomerulopathy
Malak Ghaddar, Hannah J. Lomax-Browne, H. Terence Cook, Erica Daina, Marina Noris, Giuseppe Remuzzi, Manuel Praga, Fernando Caravaca‐Fontán, Dilshani Induruwage, Matthew C. Pickering, Sean Barbour (2024). Clinical and Histological Predictors of Outcomes in C3 Glomerulopathy. , 35(10S), DOI: https://doi.org/10.1681/asn.2024vexpvzee.
Article65 days agoBaseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Steven D. Podos, Howard Trachtman, Gerald B. Appel, Andrew S. Bomback, Bradley P. Dixon, Jack F.M. Wetzels, H. Terence Cook, Samir V. Parikh, Matthew C. Pickering, James Tumlin, Craig B. Langman, Liz Lightstone, C. John Sperati, Erica Daina, Koenraad Peter Bouman, Kara Rice, Jane A. Thanassi, Mingjun Huang, Carla Nester, Giuseppe Remuzzi (2022). Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan. , 53(10), DOI: https://doi.org/10.1159/000527166.
Article65 days ago